Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Creams: SOP for Identifying Impurities in Raw Materials for Creams – V 2.0

Posted on By

Creams: SOP for Identifying Impurities in Raw Materials for Creams – V 2.0

Standard Operating Procedure for Identifying Impurities in Raw Materials for Creams

Department Creams
SOP No. SOP/CRM/128/2025
Supersedes SOP/CRM/128/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for identifying impurities in raw materials used in the production of creams. Identifying and removing any contaminants or impurities ensures that the final cream product is safe, effective, and of the highest quality. This process is crucial for complying with regulatory standards and safeguarding consumer health.

2. Scope

This SOP applies to all raw materials used in the formulation of cream products, including active ingredients, excipients, and preservatives. The SOP covers the identification of impurities at the receiving stage, during raw material testing, and prior to the start of production.

3. Responsibilities

  • Procurement Team: Responsible for sourcing raw materials from approved suppliers and ensuring that raw materials are accompanied by the necessary certificates of analysis (CoA) to verify their purity and compliance with specifications.
  • Quality Control (QC) Team: Responsible for conducting tests to identify impurities in raw materials. This includes physical, chemical, and microbial testing
methods to detect contaminants.
  • Quality Assurance (QA) Team: Responsible for reviewing the results of impurity testing, approving raw materials for use in production, and ensuring compliance with regulatory and internal quality standards.
  • 4. Accountability

    The QC Manager is accountable for ensuring that all raw material impurities are identified accurately and promptly. The Procurement Supervisor is responsible for ensuring the raw materials meet the initial specification and are accompanied by proper documentation. The QA Manager is accountable for overseeing the approval process of raw materials based on impurity testing results.

    5. Procedure

    5.1 Pre-Test Preparation

    1. Ensure that all testing equipment, such as analytical balances, pH meters, and chromatography systems, are calibrated and ready for use.
    2. Review the supplier CoAs for each raw material to ensure that the materials meet the required specifications for purity. If the CoAs are incomplete or unavailable, initiate additional testing to confirm the purity of the materials.
    3. Ensure that all raw materials are stored according to the recommended conditions (e.g., temperature, humidity) to prevent any degradation or contamination prior to testing.

    5.2 Sample Collection

    1. Collect representative samples of raw materials for impurity testing. Samples should be taken from sealed containers to ensure they are not contaminated.
    2. Ensure that the sample is homogeneous and free from any visible contamination (e.g., foreign particles, discoloration).
    3. Label each sample clearly with the material name, batch number, sampling date, and the purpose of the test to ensure traceability during testing.

    5.3 Impurity Identification Procedure

    1. Perform a physical inspection of the sample for visible contaminants (e.g., foreign particles, color changes, or improper texture).
    2. Conduct the following tests to identify specific types of impurities:
      • Microbial Testing: Test the raw material for the presence of microbial contamination, including bacteria, yeast, and mold, using appropriate growth media and incubation conditions.
      • Heavy Metals Testing: Test for the presence of heavy metals (e.g., lead, mercury) using atomic absorption spectrometry or inductively coupled plasma (ICP) analysis.
      • Chemical Impurity Testing: Perform chemical tests such as high-performance liquid chromatography (HPLC) or gas chromatography (GC) to identify the presence of residual solvents, pesticides, or other chemicals that may be contaminants.
      • Physical Impurities: Conduct tests such as microscopy or filtration to detect physical contaminants (e.g., glass, plastic, or other particulate matter).
    3. Document all test results and the specific methods used in the Impurity Testing Log (Annexure-1).

    5.4 Interpretation of Results

    1. Compare the test results to the defined specifications for each raw material. The materials should meet the defined limits for microbial content, chemical residues, heavy metals, and physical impurities.
    2. If the impurity levels exceed the acceptable limits, mark the test as “Fail” in the Impurity Testing Log (Annexure-1).
    3. Investigate the cause of the impurity by reviewing the supplier’s records, production processes, and storage conditions. Determine whether the impurity is due to the raw material itself or contamination during handling or storage.
    4. If the raw material passes the impurity test, mark the test as “Pass” and proceed with the approval of the raw material for use in production.

    5.5 Post-Test Activities

    1. Record all test results, including batch number, sample ID, impurity levels, and corrective actions taken in the Impurity Testing Log (Annexure-1).
    2. If the material fails the impurity test, place the material in quarantine until corrective actions are implemented. Communicate with the supplier to resolve the issue, which may include requesting a replacement batch.
    3. Ensure that all deviation reports and corrective actions are documented in the Deviation Log (Annexure-2).

    5.6 Documentation and Record-Keeping

    1. Ensure that all records related to impurity testing are complete, accurate, and securely stored. This includes the Impurity Testing Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
    2. Retain all records for a minimum of two years or as required by regulatory guidelines.
    3. Ensure that records are reviewed by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

    6. Abbreviations

    • GMP: Good Manufacturing Practices
    • QC: Quality Control
    • QA: Quality Assurance
    • PPE: Personal Protective Equipment

    7. Documents

    1. Annexure-1: Impurity Testing Log
    2. Annexure-2: Deviation Log

    8. References

    • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
    • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • Pharmacopeial Monographs for Raw Material Testing

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Impurity Testing Log

    Batch Number Sample ID Sampling Date Test Type Impurity Level (CFU/g, ppm) Operator
    12345 S-001 21/01/2026 Microbial Test Pass John Doe

    Annexure-2: Deviation Log

    Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
    21/01/2026 12345 Heavy metal contamination Contacted supplier for a new batch Jane Smith

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/03/2024 1.0 Initial Version New SOP Creation QA Head
    01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
    See also  Creams: SOP for Measuring Viscosity of Cream Formulations - V 2.0
    Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

    Post navigation

    Previous Post: Analytical Method Development: Preparation and Use of Placebos in Method Development – V 2.0
    Next Post: Elixir Department: SOP for Dispensing Excipients for Oral Liquid Formulations – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version